A better way to diagnose melanoma’: La Jolla’s DermTech develops Smart Sticker for the skin

Source: LA JOLLA LIGHT, April 2022

Aiming to help people bypass a biopsy, La Jolla company DermTech has developed a skin patch to test for melanoma using genomics, or the study of a person’s genes.

DermTech, led by Chief Executive Dr. John Dobak, who has helped grow the company from four employees to nearly 300 in nine years, is “all about bringing the precision of genomics to dermatology,” he said.

Dobak, a longtime La Jolla resident who graduated from UC San Diego’s School of Medicine, said genomics “is one of the biggest revolutions in medicine ever, and it’s fundamentally changing the way medicine is practiced.”